SUMMARY Forty patients who were managed conservatively after haemorrhage from an endoscopically verified duodenal ulcer were randomised at discharge from hospital to enter a blind study of ranitidine therapy (150 mg bd) versus a placebo tablet. The patients were reendoscoped after four weeks, ulcer status defined and the trial code broken revealing that five of 20 placebo patients had healed their duodenal ulcer compared with 16 of 20 ranitidine patients (p=0001). Lifestyle parameters of both groups improved during the study period but no directly related benefit in duodenal ulcer healing could be shown. We conclude that effective anti-ulcer therapy, such as ranitidine, is required to heal a duodenal ulcer which presents with haemorrhage.
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Results
Forty patients entered the study and were equally *randomised between the ranitidine and placebo groups. Analysis of the data collected revealed that the two groups of patients were well matched, the only statistically significant difference being that smokers in the ranitidine group smoked more cigarettes per day than smokers in the placebo group (Table 1) .
At the four week postdischarge endoscopy it was found that five of the 20 patients receiving placebo tablets had healed their duodenal ulcer while 16 of the 20 patients receiving ranitidine had healed their duodenal ulcer. This difference is statistically highly significant (p=0-001; Fisher's exact test) and led to the study being terminated after only 40 patients had entered. A secondary analysis was carried out to compare the 21 patients who had a healed duodenal ulcer four weeks postdischarge with the 19 patients No significant difference was noted in lifestyle parameters or their changes during the four weeks after discharge between ranitidine (n=20) and placebo (n=20) patients, healed (n=21), and unhealed (n=19) duodenal ulcer patients and healed (n=5) and unhealed (n= 15) duodenal ulcer patients receiving the placebo preparation. Although lifestyle parameter changes did not correlate with duodenal ulcer healing, potentially beneficial changes were recorded amongst the 40 patients studied during the four week period after discharge from hospital (Table 2) .
Discussion
Ulcer healing is generally accepted as a criteria of successful short term conservative management of a duodenal ulcer which has bled but has not led to urgent surgery. This study has shown that in this situation the use of an H2 receptor antagonist such as ranitidine will achieve a significantly greater duodenal ulcer healing rate than placebo therapy. Our four week duodenal ulcer healing rates, as defined by endoscopy, were strikingly different for the two groups of patients studied. We are unaware that complete healing of a duodenal ulcer using full dose cimetidine therapy is associated with a significantly lower recurrent ulcer rate than if full dose therapy is reduced or stopped before complete duodenal ulcer healing."
The relationship between complete duodenal ulcer healing and the success of further medical management of the ulcer diathesis may well be important. The results of this study support the general view that the absence of dyspepsia does not correlate well with duodenal ulcer healing. Patients who leave hospital with an active duodenal ulcer which has bled should therefore undergo a further endoscopy to ensure that H2 receptor antagonist therapy has completely healed the duodenal ulcer before the dose is reduced to maintenance level or therapy stopped.
The hypothesis that potentially beneficial changes in lifestyle parameters will encourage spontaneous duodenal ulcer healing after presentation with haemorrhage cannot be supported by this study. Our observations suggest that the majority of the study patients did alter at least one aspect of their lifestyle in an apparently beneficial way during the four weeks after discharge from hospital. Despite these observations we were unable to correlate short term postdischarge lifestyle changes with duodenal ulcer healing and conclude that beneficial lifestyle changes, even if they do occur, cannot be relied upon to induce satisfactory spontaneous duodenal ulcer healing in patients who have presented with haemorrhage. 
